View in EDS HTML Full Text PDF Full Text

Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.

Saved in:
Bibliographic Details
Title: Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
Authors: Olson, Robert1 (AUTHOR) rolson2@bccancer.bc.ca, Mathews, Lindsay1 (AUTHOR), Liu, Mitchell2 (AUTHOR), Schellenberg, Devin3 (AUTHOR), Mou, Benjamin4 (AUTHOR), Berrang, Tanya5 (AUTHOR), Harrow, Stephen6 (AUTHOR), Correa, Rohann J. M.7 (AUTHOR), Bhat, Vasudeva7 (AUTHOR), Pai, Howard5 (AUTHOR), Mohamed, Islam4 (AUTHOR), Miller, Stacy1 (AUTHOR), Schneiders, Famke8 (AUTHOR), Laba, Joanna7 (AUTHOR), Wilke, Derek9 (AUTHOR), Senthi, Sashendra10 (AUTHOR), Louie, Alexander V.11 (AUTHOR), Swaminath, Anand8 (AUTHOR), Chalmers, Anthony12 (AUTHOR), Gaede, Stewart7 (AUTHOR)
Source: BMC Cancer. 5/5/2020, Vol. 20 Issue 1, p1-12. 12p. 2 Diagrams, 2 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-020-06876-4